LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 2352-2367

  Häbig, Karina ^a   Gellhaar, Sandra ^b   Heim, Birgit ^a   Djuric, Verena ^a   Giesert, Florian ^c   Wurst, Wolfgang ^c,d,e,f   Walter, Carolin ^a   Hentrich, Thomas ^a   Riess, Olaf ^a   Bonin, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Actin cytoskeleton; Growth cone; Neurite outgrowth; Parkinson's disease

Indexed keywords

ARHGEF7 PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; LEUCINE RICH REPEAT KINASE 2; SMALL INTERFERING RNA; TROPOMYOSIN; TROPOMYOSIN 4; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE SILENCING; GENETIC TRANSCRIPTION; GROWTH CONE; HIPPOCAMPUS; MICROARRAY ANALYSIS; MOUSE; NERVE FIBER GROWTH; NEURITE; NEUROBLASTOMA CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 84885943281     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.09.009     Document Type: Article

References (52)

1. Paisan-Ruiz C. LRRK2 gene variation and its contribution to Parkinson disease. Hum. Mutat. 2009, 30:1153-1160.
2. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Muller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.
3. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., Lopez de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Marti-Masso J.F., Perez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
4. Aasly J.O., Vilarino-Guell C., Dachsel J.C., Webber P.J., West A.B., Haugarvoll K., Johansen K.K., Toft M., Nutt J.G., Payami H., Kachergus J.M., Lincoln S.J., Felic A., Wider C., Soto-Ortolaza A.I., Cobb S.A., White L.R., Ross O.A., Farrer M.J. Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease. Mov. Disord. 2010 Oct 15, 25(13):2156-2163. 10.1002/mds.23265.
5. Haebig K., Gloeckner C.J., Miralles M.G., Gillardon F., Schulte C., Riess O., Ueffing M., Biskup S., Bonin M. ARHGEF7 (Beta-PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2. PLoS One 2010, 5:e13762.
6. Nichols W.C., Pankratz N., Hernandez D., Paisan-Ruiz C., Jain S., Halter C.A., Michaels V.E., Reed T., Rudolph A., Shults C.W., Singleton A., Foroud T. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005, 365:410-412.
7. Di Fonzo A., Rohe C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., Guedes L., Fabrizio E., Manfredi M., Vanacore N., Goldwurm S., Breedveld G., Sampaio C., Meco G., Barbosa E., Oostra B.A., Bonifati V. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005, 365:412-415.
8. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., Shaw K., Bhatia K.P., Bonifati V., Quinn N.P., Lynch J., Healy D.G., Holton J.L., Revesz T., Wood N.W. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005, 365:415-416.
9. Samann J., Hegermann J., Gromoff E.V., Eimer S., Baumeister R., Schmidt E. Caenorhabditis elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth. J. Biol. Chem. 2009 Jun 12, 284(24):16482-16491. http://dx.doi.org/10.1074/jbc.M808255200. Epub 2009 Feb 27.
10. Sakaguchi-Nakashima A., Meir J.Y., Jin Y., Matsumoto K., Hisamoto N. LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic polarity of SV proteins. Curr. Biol. 2007, 17:592-598.
11. Winner B., Melrose H.L., Zhao C., Hinkle K.M., Yue M., Kent C., Braithwaite A.T., Ogholikhan S., Aigner R., Winkler J., Farrer M.J., Gage F.H. Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice. Neurobiol. Dis. 2011, 41:706-716.
12. MacLeod D., Dowman J., Hammond R., Leete T., Inoue K., Abeliovich A. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006, 52:587-593.
13. Plowey E.D., Cherra S.J., Liu Y.J., Chu C.T. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J. Neurochem. 2008 May, 105(3):1048-1056. http://dx.doi.org/10.1111/j.1471-4159.2008.05217.x. Epub 2008 Jan 7.
14. Dachsel J.C., Behrouz B., Yue M., Beevers J.E., Melrose H.L., Farrer M.J. A comparative study of Lrrk2 function in primary neuronal cultures. Parkinsonism Relat. Disord. 2010, 16:650-655.
15. Gillardon F. Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in parkinsonian neurodegeneration?. J. Neurochem. 2009, 110:1514-1522.
16. Jaleel M., Nichols R.J., Deak M., Campbell D.G., Gillardon F., Knebel A., Alessi D.R. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem. J. 2007, 405:307-317.
17. Gandhi P.N., Wang X., Zhu X., Chen S.G., Wilson-Delfosse A.L. The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J. Neurosci. Res. 2008 Jun, 86(8):1711-1720. 10.1002/jnr.21622.
18. Gillardon F. Interaction of elongation factor 1-alpha with leucine-rich repeat kinase 2 impairs kinase activity and microtubule bundling in vitro. Neuroscience 2009, 163:533-539.
19. Habig K., Walter M., Poths S., Riess O., Bonin M. RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player. Neurogenetics 2008, 9:83-94.
20. Sancho R.M., Law B.M., Harvey K. Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. Hum. Mol. Genet. 2009, 18:3955-3968.
21. Mutez E., Larvor L., Lepretre F., Mouroux V., Hamalek D., Kerckaert J.P., Perez-Tur J., Waucquier N., Vanbesien-Mailliot C., Duflot A., Devos D., Defebvre L., Kreisler A., Frigard B., Destee A., Chartier-Harlin M.C. Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation. Neurobiol. Aging 2011, 32:1839-1848.
22. Chan D., Citro A., Cordy J.M., Shen G.C., Wolozin B. RAC1 rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J. Biol. Chem. 2011 May 6, 286(18):16140-16149. http://dx.doi.org/10.1074/jbc.M111.234005. Epub 2011 Mar 16.
23. Meixner A., Boldt K., Van Troys M., Askenazi M., Gloeckner C.J., Bauer M., Marto J.A., Ampe C., Kinkl N., Ueffing M. A quick screen for Lrrk2 interaction partners - leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics. Mol. Cell Proteomics 2011 Jan, 10(1). M110.001172, http://dx.doi.org/10.1074/mcp.M110.001172. Epub 2010 Sep 27.
24. Parisiadou L., Xie C., Cho H.J., Lin X., Gu X.L., Long C.X., Lobbestael E., Baekelandt V., Taymans J.M., Sun L., Cai H. Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J. Neurosci. 2009, 29:13971-13980.
25. Manser E., Loo T.H., Koh C.G., Zhao Z.S., Chen X.Q., Tan L., Tan I., Leung T., Lim L. PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol. Cell 1998, 1:183-192.
26. Bagrodia S., Taylor S.J., Jordon K.A., Van Aelst L., Cerione R.A. A novel regulator of p21-activated kinases. J. Biol. Chem. 1998, 273:23633-23636.
27. Shin E.Y., Lee C.S., Cho T.G., Kim Y.G., Song S., Juhnn Y.S., Park S.C., Manser E., Kim E.G. BetaPak-interacting exchange factor-mediated Rac1 activation requires smgGDS guanine nucleotide exchange factor in basic fibroblast growth factor-induced neurite outgrowth. J. Biol. Chem. 2006, 281:35954-35964.
28. Shin E.Y., Woo K.N., Lee C.S., Koo S.H., Kim Y.G., Kim W.J., Bae C.D., Chang S.I., Kim E.G. Basic fibroblast growth factor stimulates activation of Rac1 through a p85 betaPIX phosphorylation-dependent pathway. J. Biol. Chem. 2004, 279:1994-2004.
29. Paus M., Kohl Z., Ben Abdallah N.M., Galter D., Gillardon F., Winkler J. Enhanced dendritogenesis and axogenesis in hippocampal neuroblasts of LRRK2 knockout mice. Brain Res. 2013 Feb 25, 1497:85-100. http://dx.doi.org/10.1016/j.brainres.2012.12.024. Epub 2012 Dec 25.
30. Hitz C., Steuber-Buchberger P., Delic S., Wurst W., Kuhn R. Generation of shRNA transgenic mice. Methods Mol. Biol. 2009, 530:101-129.
31. Delic S., Streif S., Deussing J.M., Weber P., Ueffing M., Holter S.M., Wurst W., Kuhn R. Genetic mouse models for behavioral analysis through transgenic RNAi technology. Genes Brain Behav. 2008, 7:821-830.
32. Kapfhammer J.P., Xu H., Raper J.A. The detection and quantification of growth cone collapsing activities. Nat. Protoc. 2007, 2:2005-2011.
33. Bichelmeier U., Schmidt T., Hubener J., Boy J., Ruttiger L., Habig K., Poths S., Bonin M., Knipper M., Schmidt W.J., Wilbertz J., Wolburg H., Laccone F., Riess O. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J. Neurosci. 2007, 27:7418-7428.
34. Pollard T.D., Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003, 112:453-465.
35. Heo H.Y., Kim K.S., Seol W. Coordinate regulation of neurite outgrowth by LRRK2 and its interactor, Rab5. Exp. Neurobiol. 2010, 19:97-105.
36. Wang C.L., Coluccio L.M. New insights into the regulation of the actin cytoskeleton by tropomyosin. Int. Rev. Cell Mol. Biol. 2010, 281:91-128.
37. Ridley A.J. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 2006, 16:522-529.
38. Bernard O., kinases Lim Regulators of actin dynamics. Int. J. Biochem. Cell Biol. 2007, 39:1071-1076.
39. Gunning P., Hardeman E., Jeffrey P., Weinberger R. Creating intracellular structural domains: spatial segregation of actin and tropomyosin isoforms in neurons. Bioessays 1998, 20:892-900.
40. Schevzov G., Bryce N.S., Almonte-Baldonado R., Joya J., Lin J.J., Hardeman E., Weinberger R., Gunning P. Specific features of neuronal size and shape are regulated by tropomyosin isoforms. Mol. Biol. Cell 2005, 16:3425-3437.
41. Fath T., Agnes Chan Y.K., Vrhovski B., Clarke H., Curthoys N., Hook J., Lemckert F., Schevzov G., Tam P., Watson C.M., Khoo P.L., Gunning P. New aspects of tropomyosin-regulated neuritogenesis revealed by the deletion of Tm5NM1 and 2. Eur. J. Cell Biol. 2010, 89:489-498.
42. Bugyi B., Didry D., Carlier M.F. How tropomyosin regulates lamellipodial actin-based motility: a combined biochemical and reconstituted motility approach. EMBO J. 2010, 29:14-26.
43. Blanchoin L., Pollard T.D., Hitchcock-DeGregori S.E. Inhibition of the Arp2/3 complex-nucleated actin polymerization and branch formation by tropomyosin. Curr. Biol. 2001, 11:1300-1304.
44. Cherra S.J., Steer E., Gusdon A.M., Kiselyov K., Chu C.T. Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons. Am. J. Pathol. 2013, 182:474-484.
45. Tong Y., Pisani A., Martella G., Karouani M., Yamaguchi H., Pothos E.N., Shen J. R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14622-14627.
46. Had L., Faivre-Sarrailh C., Legrand C., Mery J., Brugidou J., Rabie A. Tropomyosin isoforms in rat neurons: the different developmental profiles and distributions of TM-4 and TMBr-3 are consistent with different functions. J. Cell Sci. 1994, 107(Pt 10):2961-2973.
47. Shin E.Y., Shin K.S., Lee C.S., Woo K.N., Quan S.H., Soung N.K., Kim Y.G., Cha C.I., Kim S.R., Park D., Bokoch G.M., Kim E.G. Phosphorylation of p85 beta PIX, a Rac/Cdc42-specific guanine nucleotide exchange factor, via the Ras/ERK/PAK2 pathway is required for basic fibroblast growth factor-induced neurite outgrowth. J. Biol. Chem. 2002, 277:44417-44430.
48. Liou A.K., Leak R.K., Li L., Zigmond M.J. Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway. Neurobiol. Dis. 2008, 32:116-124.
49. Carballo-Carbajal I., Weber-Endress S., Rovelli G., Chan D., Wolozin B., Klein C.L., Patenge N., Gasser T., Kahle P.J. Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway. Cell. Signal. 2010, 22:821-827.
50. Kalil K., Szebenyi G., Dent E.W. Common mechanisms underlying growth cone guidance and axon branching. J. Neurobiol. 2000, 44:145-158.
51. Szebenyi G., Dent E.W., Callaway J.L., Seys C., Lueth H., Kalil K. Fibroblast growth factor-2 promotes axon branching of cortical neurons by influencing morphology and behavior of the primary growth cone. J. Neurosci. 2001, 21:3932-3941.
52. Dent E.W., Tang F., Kalil K. Axon guidance by growth cones and branches: common cytoskeletal and signaling mechanisms. Neuroscientist 2003, 9:343-353.